2012
DOI: 10.1186/2001-1326-1-19
|View full text |Cite
|
Sign up to set email alerts
|

The impact of saliva collection and processing methods on CRP, IgE, and Myoglobin immunoassays

Abstract: Background Owing to its ease of collection, saliva is potentially the sample of choice in diagnosis. Salivary biomolecules have provided a porthole in surveying a person's health and well‐being. Our study aims were (1) to demonstrate the effects of pre‐analytical steps, collection and pre‐processing techniques on salivary protein detection and (2) to establish an indication of salivary reference intervals for 3 biomolecules of clinical interest. Methods Saliva samples were collected from participants (n = 25, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
106
1
1

Year Published

2013
2013
2023
2023

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 131 publications
(118 citation statements)
references
References 35 publications
(53 reference statements)
3
106
1
1
Order By: Relevance
“…Therefore, monoclonal antibodies that target the nonglycosylated sites between NTproBNP 28 -45 [i.e., NT-proBNP 30 -35 (Glu-Leu-GlnVal-Glu-Gln motif)] are likely to exclude the effects of O-glycosylation on the measurement of plasma NTproBNP. This, together with monoclonal antibodies targeting NT-proBNP [13][14][15][16][17][18][19][20] , is likely to provide a more standardized measurement of the plasma NT-proBNP for future "sandwich" immunoassays. Our data indicated that although immunoreactive NT-proBNP was present in human plasma as multiple fragments of the full-length NT-proBNP molecule, specific epitopes of the peptide appear to be more abundant, providing ideal targets for developing the next generation diagnostic assays for clinical use.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Therefore, monoclonal antibodies that target the nonglycosylated sites between NTproBNP 28 -45 [i.e., NT-proBNP 30 -35 (Glu-Leu-GlnVal-Glu-Gln motif)] are likely to exclude the effects of O-glycosylation on the measurement of plasma NTproBNP. This, together with monoclonal antibodies targeting NT-proBNP [13][14][15][16][17][18][19][20] , is likely to provide a more standardized measurement of the plasma NT-proBNP for future "sandwich" immunoassays. Our data indicated that although immunoreactive NT-proBNP was present in human plasma as multiple fragments of the full-length NT-proBNP molecule, specific epitopes of the peptide appear to be more abundant, providing ideal targets for developing the next generation diagnostic assays for clinical use.…”
Section: Discussionmentioning
confidence: 99%
“…The NTproBNP standards were prepared using pooled plasma collected from healthy volunteers (n ϭ 10) and mixing it with the High Block immunoassay buffer in a ratio of 50%:50%. This enabled us to overcome the matrix (A), The 6 immunoassays use diagnostic-grade monoclonal antibodies to detect NT-proBNP [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20] , NT-proBNP , NT-proBNP , NT-proBNP 28 -76 , NT-proBNP , and NT-proBNP . N-and C-terminal proteolytic sites detected by our MS analysis are shown with red vertical lines.…”
Section: Plasma Nt-probnp Alphalisa Immunoassaysmentioning
confidence: 99%
See 1 more Smart Citation
“…All participants gave informed consent before sample collection. Whole-mouth saliva was collected from healthy, resting control individuals (n ϭ 9) and patients (n ϭ 8), as previously described (11)(12)(13)(14). Saliva was collected in DNase-and RNase-free Falcon tubes (50 mL), frozen immediately on dry ice, and stored at Ϫ80°C until further analysis.…”
mentioning
confidence: 99%
“…The most common forms of saliva collection include (1) the passive drool technique (Christodoulides et al, 2005), where saliva is accumulated in the floor of the mouth for a defined period of time and then spat into a test tube where some few mL are collected and (2) the absorbent device technique, which uses elements such as swabs to sample the saliva, which can be directly integrated into lateral flow immunoassays, such as the commercial devices used for HIV testing (Dewsnap and Mcowan, 2006;Zelin et al, 2008;Mohamed et al, 2012).…”
Section: Sample Extractionmentioning
confidence: 99%